Skip to main content
x
About searching

Search results

  1. ASCO 2025 – 3SBio reveals what Pfizer got for its $1.25bn

    ASCO 2025 – 3SBio reveals what Pfizer got for its $1.25bn …

    - 06/01/2025 - 21:06

  2. ASCO 2025 – Exelixis’s son of Cabometyx improves

    ASCO 2025 – Exelixis’s son of Cabometyx improves …

    - 06/02/2025 - 23:16

  3. ASCO 2025 – zilo-V adds a patient death to its tox tally

    ASCO 2025 – zilo-V adds a patient death to its tox tally …

    - 06/01/2025 - 21:07

  4. ASCO 2025 – Astra's Matterhorn could break new ground

    ASCO 2025 – Astra's Matterhorn could break new ground …

    - 06/01/2025 - 21:22

  5. ASCO 2025 – Astra seeks a new SERD paradigm

    ASCO 2025 – Astra seeks a new SERD paradigm …

    - 06/02/2025 - 14:04

  6. ASCO 2025 – Enhertu mounts its first-line charge

    ASCO 2025 – Enhertu mounts its first-line charge … HR=0.56; p<0.00001 HR=0.62, p<0.0001 Source: ASCO 2025, Perjeta label.   Discussing the results at …

    - 06/02/2025 - 19:46

  7. ASCO 2025 – Trodelvy heads for the front line

    ASCO 2025 – Trodelvy heads for the front line … 31% TEAE-related death 3% 3% Source: ASCO 2025.   Ascent-04 also saw an “early trend” …

    - 06/01/2025 - 21:07

  8. ASCO 2025 – vepdegestrant matches rival degraders

    ASCO 2025 – vepdegestrant matches rival degraders …

    - 06/01/2025 - 21:07

  9. ASCO 2025 – Braftovi breaks new ground

    ASCO 2025 – Braftovi breaks new ground …

    - 05/31/2025 - 14:02

  10. ASCO 2025 preview – KRAS challengers assemble

    ASCO 2025 preview – KRAS challengers assemble … when their titles were revealed .   Selected ASCO 2025 regular presentations for small molecules …

    - 05/28/2025 - 10:07